Mesosil Analysis: $6M Raised
What is Mesosil?
Mesosil develops a silica-based platform for sustained release of bioactive agents, significantly reducing infection rates in dental materials and other medical applications. Their technology is designed to integrate into existing manufacturing processes, providing long-term antimicrobial protection across various medical fields.
Location
124 Edward St, Toronto, Ontario M5G 1G6, Canada
Employees
1-10
Founded
2018
Funding Status
Seed
Product Features & Capabilities
- Mesosil® 500 platform for sustained release
- Antimicrobial additives for dental materials
- Customized solutions for medical devices
- Scalable synthesis of anti-infective materials
Use Cases
Reduce recurrent tooth decay by up to 80% in dental applications; Address biofouling in medical devices; Provide long-term antimicrobial protection in orthopedic implants; Collaborate on custom anti-infective solutions; Integrate into existing manufacturing workflows
Other Considerations
ISO13485:2016 certified for quality management; Focused on scalable synthesis of custom products; Expertise in anti-infective materials development
See something that needs updating? Suggest edits to this profile.